About this webinar
Recent technological developments have provided many researchers with the opportunity to look into tissues with unprecedented detail. This is transforming our understanding of immunity and how immune cells interact with and are influenced by the tissue microenvironment.
In this webinar, Professor Simon Milling, Editor-in-Chief of Discovery Immunology will be joined by Professor Arne Akbar, Dr Stephanie Dougan and Professor Leonie Taams who will discuss examples of their recent research that has advanced our understanding of tissue immunology and immunity in health and disease.
Professor Tim Elliott, Editor-in-Chief of Immunotherapy Advances will join for a Q&A session at the end of the webinar.
Attendees will have the chance to ask questions to the panel during the Q&A. You can ask questions in advance – please submit this via the link in the registration confirmation email and we’ll cover as many as we can on the day.
Registration is now open. Click here to register. Please join us for what promises to be a highly interesting event!
Thursday 21 September, 14:00–15:30 BST
- Opening remarks and introduction – Professor Simon Milling
- 'Immunity: location, location, location' – Professor Arne Akbar
- ‘Why is pancreatic cancer so resistant to immunotherapy – clues from the tumour microenvironment’ – Dr Stephanie Dougan
- 'Teasing out the T cells in the inflamed joint’ – Professor Leonie Taams
- Questions & answers
- Closing remarks – Professor Simon Milling
Hosted by the British Society for Immunology journals.
Professor Simon Milling, Chair
Professor of Immunology and Deputy Head of Research Area (Immunology), University of Glasgow, UK
Editor-in-Chief of Discovery Immunology
Professor Arne Akbar – 'Immunity: location, location, location'
Professor of Immunology, Division of Medicine, University College London, UK
Former President of the British Society for Immunology
Dr Stephanie Dougan – 'Why is pancreatic cancer so resistant to immunotherapy – clues from the tumour microenvironment'
Associate Professor of Immunology and Investigator in Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, USA
Deputy Editor of Immunotherapy Advances
Professor Leonie Taams – 'Teasing out the T cells in the inflamed joint’
Head of the Department of Inflammation Biology and Director of the Centre for Inflammation Biology & Cancer Immunology, King's College London, UK
Editor-in-Chief of Clinical & Experimental Immunology
Professor Tim Elliott
Kidani Professor of Immuno-oncology and Co-Director of Cancer Research UK Oxford Centre, University of Oxford, UK
Editor-in-Chief of Immunotherapy Advances
Clinical & Experimental Immunology focuses on translational immunology, in particular studies that have the potential to transform our understanding of the immunopathology of human disease and/or change clinical practice.
Clinical & Experimental Immunology recently published a new Review Series: Therapeutic opportunities for regulatory T cell enhancing approaches. Find out more.
Immunotherapy Advances is a fully Open Access journal covering the translational pipeline for immunotherapy, from discovery research through to clinical trials. Experimental medicine and first-in-human clinical studies are welcomed.
Immunotherapy Advances is currently inviting manuscripts for an upcoming Special Collection on Human vaccine challenge models. Find out more and submit your manuscript.
Discovery Immunology is a fully Open Access journal focusing on basic aspects of cellular or molecular immunology. The journal also welcomes articles describing discovery science with relevance to infection biology, inflammation or immune-mediated pathogenesis.
Discovery Immunology is currently inviting manuscripts for publication in an upcoming Special Collection: T cells at barrier sites. Find out more and submit your manuscript.